S. Pilari,  L. Fronton and W. Huisinga

Monoclonal Antibody Disposition beyond Target Binding: Impact of FcRn on Clearance and Derivation of Mechanistic Compartment Models

Submitted (2011).

W. Huisinga, A. Solms, L. Fronton and S. Pilari

Modeling inter-individual variability in physiologically-based pharmacokinetics and its link to mechanistic covariate modeling

CPT: Pharmacometrics & Systems Pharmacology, 1 (2012), e4.

Journal (open access), Suppl Material (Data & Matlab code)

B. You, M. Pollet-Villard, L. Fronton, C. Labrousse, A.M. Schott, T. Hajri, P. Girard, et al.

Predictive values of hCG clearance for risk of methotrexate resistance in low risk gestational trophoblastic neoplasia.

Ann Oncol.,  21 (2010), pp. 1643-50.

 Journal

B. You, L. Fronton, H. Boyle, J.P. Droz, P. Girard, B. Tranchand, B. Ribba, M., H. Coquelin, A. Fléchon

Predictive value of modeled AUC (AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.

Urology, 76 (2010), pp. 423-9.e2.

Journal

L. Fronton

Population pharmacokinetic analysis of a 5-HT4 agonist in the treatment of GERD

MSc Pharmacokinetics, Faculty of Pharmacy, Paris V, 2007.